Aniket P. Sarkate - Search Results

Year	Number of Results
2007	1
2008	2
2009	2
2011	1
2016	2
2017	3
2018	1
2019	1
2020	5
2021	6
2022	3
2023	4
2024	1

1

Design, synthesis, and biological evaluation of novel 2,3-Di-O-Aryl/Alkyl sulfonate derivatives of l-ascorbic acid: Efficient access to novel anticancer agents via in vitro screening, tubulin polymerization inhibition, molecular docking study and ADME predictions.

Deshmukh SR, Nalkar AS, Sarkate AP, Tiwari SV, Lokwani DK, Thopate SR. Deshmukh SR, et al. Among authors: sarkate ap. Bioorg Chem. 2024 Apr 26;147:107402. doi: 10.1016/j.bioorg.2024.107402. Online ahead of print. Bioorg Chem. 2024. PMID: 38688199

2

Molecular Docking, Pharmacokinetic and Molecular Simulation Analysis of Novel Mono-Carbonyl Curcumin Analogs as L858R/T790M/C797S Mutant EGFR Inhibitors.

Bhandari SV, Kuthe PV, Patil SM, Nagras OG, Sarkate AP, Chaudhari SY, Surve SV. Bhandari SV, et al. Among authors: sarkate ap. Chem Biodivers. 2023 Nov;20(11):e202301081. doi: 10.1002/cbdv.202301081. Epub 2023 Oct 26. Chem Biodivers. 2023. PMID: 37793119

3

A Review: Exploring Synthetic Schemes and Structure-activity Relationship (SAR) Studies of Mono-carbonyl Curcumin Analogues for Cytotoxicity Inhibitory Anticancer Activity.

Bhandari SV, Kuthe P, Patil SM, Nagras O, Sarkate AP. Bhandari SV, et al. Curr Org Synth. 2023;20(8):821-837. doi: 10.2174/1570179420666230126142238. Curr Org Synth. 2023. PMID: 36703591 Review.

4

Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions.

Kardile RA, Sarkate AP, Lokwani DK, Tiwari SV, Azad R, Thopate SR. Kardile RA, et al. Among authors: sarkate ap. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114889. doi: 10.1016/j.ejmech.2022.114889. Epub 2022 Oct 29. Eur J Med Chem. 2023. PMID: 36375337

5

Molecular dynamic simulations based discovery and development of thiazolidin-4-one derivatives as EGFR inhibitors targeting resistance in non-small cell lung cancer (NSCLC).

Karnik KS, Sarkate AP, Lokwani DK, Tiwari SV, Azad R, Wakte PS. Karnik KS, et al. Among authors: sarkate ap. J Biomol Struct Dyn. 2023 Jul;41(10):4696-4710. doi: 10.1080/07391102.2022.2071339. Epub 2022 May 9. J Biomol Struct Dyn. 2023. PMID: 35532095

6

Explorations of novel pyridine-pyrimidine hybrid phosphonate derivatives as aurora kinase inhibitors.

Tiwari SV, Sarkate AP, Lokwani DK, Pansare DN, Gattani SG, Sheaikh SS, Jain SP, Bhandari SV. Tiwari SV, et al. Among authors: sarkate ap. Bioorg Med Chem Lett. 2022 Jul 1;67:128747. doi: 10.1016/j.bmcl.2022.128747. Epub 2022 Apr 26. Bioorg Med Chem Lett. 2022. PMID: 35476959

7

Free energy perturbation guided Synthesis with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).

Karnik KS, Sarkate AP, Tiwari SV, Azad R, Wakte PS. Karnik KS, et al. Among authors: sarkate ap. Bioorg Chem. 2021 Oct;115:105226. doi: 10.1016/j.bioorg.2021.105226. Epub 2021 Jul 31. Bioorg Chem. 2021. PMID: 34364055

8

Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.

Kardile RA, Sarkate AP, Borude AS, Mane RS, Lokwani DK, Tiwari SV, Azad R, Burra PVLS, Thopate SR. Kardile RA, et al. Among authors: sarkate ap. Bioorg Chem. 2021 Oct;115:105174. doi: 10.1016/j.bioorg.2021.105174. Epub 2021 Jul 16. Bioorg Chem. 2021. PMID: 34314913

9

One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.

Sarkate AP, Dofe VS, Tiwari SV, Lokwani DK, Karnik KS, Kamble DD, Ansari MHSH, Dodamani S, Jalalpure SS, Sangshetti JN, Azad R, Burra PVLS, Bhandari SV. Sarkate AP, et al. Bioorg Med Chem Lett. 2021 May 15;40:127916. doi: 10.1016/j.bmcl.2021.127916. Epub 2021 Mar 6. Bioorg Med Chem Lett. 2021. PMID: 33689875

10

Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).

Karnik KS, Sarkate AP, Tiwari SV, Azad R, Burra PVLS, Wakte PS. Karnik KS, et al. Among authors: sarkate ap. Bioorg Chem. 2021 Feb;107:104612. doi: 10.1016/j.bioorg.2020.104612. Epub 2021 Jan 5. Bioorg Chem. 2021. PMID: 33476869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year